Item 2.02 Results of Operations and Financial Condition.

On May 11, 2020, Menlo Therapeutics Inc. issued a press release announcing its financial results for the quarter ended March 31, 2020. The press release is being furnished as Exhibit 99.1.

The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits

The following exhibit is being furnished herewith.

Exhibit No. Description

99.1 Press release, dated May 11, 2020.

© Edgar Online, source Glimpses